MAIA Biotechnology Inc (MAIA)
3.28
+0.13
(+4.13%)
USD |
NYAM |
May 03, 16:00
3.22
-0.06
(-1.83%)
After-Hours: 20:00
MAIA Biotechnology Free Cash Flow (Quarterly): -3.992M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -3.992M |
September 30, 2023 | -3.157M |
June 30, 2023 | -2.561M |
March 31, 2023 | -3.361M |
December 31, 2022 | -2.950M |
September 30, 2022 | -4.319M |
Date | Value |
---|---|
June 30, 2022 | -2.019M |
March 31, 2022 | -2.808M |
December 31, 2021 | -1.607M |
September 30, 2021 | -1.311M |
June 30, 2021 | -0.951M |
March 31, 2021 | -0.2533M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.319M
Minimum
Sep 2022
-0.2533M
Maximum
Mar 2021
-2.441M
Average
-2.684M
Median
Free Cash Flow (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | -3.91M |
Avid Bioservices Inc | -0.801M |
Oragenics Inc | -1.102M |
NeuBase Therapeutics Inc | -2.003M |
Viking Therapeutics Inc | -6.134M |